BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396
104 results:

  • 1. TGF-β1/smad3-driven GLI2 isoform expression contributes to aggressive phenotypes of hepatocellular carcinoma.
    Ding J; Yang YY; Li PT; Ma Y; Zhang L; Zhou Y; Jin C; Li HY; Zhu YF; Liu XP; Liu ZJ; Jia HL; Liu PG; Wu J
    Cancer Lett; 2024 Apr; 588():216768. PubMed ID: 38453045
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer.
    Zhu Y; Fang S; Fan B; Xu K; Xu L; Wang L; Zhu L; Chen C; Wu R; Ni J; Wang J
    Theranostics; 2024; 14(4):1683-1700. PubMed ID: 38389839
    [No Abstract]    [Full Text] [Related]  

  • 3. Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/smad pathway.
    Wang Y; Zhang A; Li Q; Liu C
    J Ethnopharmacol; 2024 May; 326():117872. PubMed ID: 38325667
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The emerging roles of CEACAM6 in human cancer (Review).
    Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
    Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Somatostatin Inhibited the EMT of pancreatic cancer Cells by Mediating the TGF-β/smad Signaling Pathway.
    Zhou X; Wang W; Liu L
    Discov Med; 2023 Dec; 35(179):1086-1092. PubMed ID: 38058074
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An NFATc1/smad3/cJUN Complex Restricted to smad4-Deficient pancreatic cancer Guides Rational Therapies.
    Hasselluhn MC; Schlösser D; Versemann L; Schmidt GE; Ulisse M; Oschwald J; Zhang Z; Hamdan F; Xiao H; Kopp W; Spitalieri J; Kellner C; Schneider C; Reutlinger K; Nagarajan S; Steuber B; Sastra SA; Palermo CF; Appelhans J; Bohnenberger H; Todorovic J; Kostyuchek I; Ströbel P; Bockelmann A; König A; Ammer-Herrmenau C; Schmidleitner L; Kaulfuß S; Wollnik B; Hahn SA; Neesse A; Singh SK; Bastians H; Reichert M; Sax U; Olive KP; Johnsen SA; Schneider G; Ellenrieder V; Hessmann E
    Gastroenterology; 2024 Feb; 166(2):298-312.e14. PubMed ID: 37913894
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. circEIF3I facilitates the recruitment of smad3 to early endosomes to promote TGF-β signalling pathway-mediated activation of MMPs in pancreatic cancer.
    Zhao Z; Yang W; Kong R; Zhang Y; Li L; Song Z; Chen H; Luo Y; Zhang T; Cheng C; Li G; Liu D; Geng X; Chen H; Wang Y; Pan S; Hu J; Sun B
    Mol Cancer; 2023 Sep; 22(1):152. PubMed ID: 37689715
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/smad3 pathway.
    Deng L; Bao W; Zhang B; Zhang S; Chen Z; Zhu X; He B; Wu L; Chen X; Deng T; Chen B; Yu Z; Wang Y; Chen G
    Cell Death Dis; 2023 Sep; 14(9):590. PubMed ID: 37669935
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art.
    Lu G; Wang X; Cheng M; Wang S; Ma K
    Biomed Pharmacother; 2023 Sep; 165():115132. PubMed ID: 37423169
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long-term (10-year) outcomes and prognostic factors in resected intraductal papillary mucinous neoplasm tumors in Finland: A nationwide retrospective study.
    Vaalavuo Y; Vornanen M; Ahola R; Antila A; Rinta-Kiikka I; Sand J; Laukkarinen J
    Surgery; 2023 Jul; 174(1):75-82. PubMed ID: 37062604
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cost-effectiveness analysis of computer-aided detection systems for colonoscopy in Japan.
    Sekiguchi M; Igarashi A; Toyoshima N; Takamaru H; Yamada M; Esaki M; Kobayashi N; Saito Y
    Dig Endosc; 2023 Nov; 35(7):891-899. PubMed ID: 36752676
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. NamiRNA-enhancer network of miR-492 activates the NR2C1-TGF-β/smad3 pathway to promote epithelial-mesenchymal transition of pancreatic cancer.
    Liu S; He X; Di Y; Li Q; Li F; Ma Y; Chen L; Gao Y; Xu J; Yang S; Xu L; Corpe C; Ling Y; Zhang X; Xu J; Yu W; Wang J
    Carcinogenesis; 2023 May; 44(2):153-165. PubMed ID: 36591938
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Loss of tumor suppressor WWOX accelerates pancreatic cancer development through promotion of TGFβ/BMP2 signaling.
    Husanie H; Abu-Remaileh M; Maroun K; Abu-Tair L; Safadi H; Atlan K; Golan T; Aqeilan RI
    Cell Death Dis; 2022 Dec; 13(12):1074. PubMed ID: 36572673
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A novel germline smad4 variant detected in a Japanese family with juvenile polyposis syndrome and hereditary hemorrhagic telangiectasia.
    Kananazawa Y; Yamada T; Yamaguchi T; Saito Y; Kakinuma D; Masuda Y; Ando F; Ohashi R; Eguchi H; Okazaki Y; Ishida H; Yoshida H
    Jpn J Clin Oncol; 2023 Mar; 53(3):275-279. PubMed ID: 36546711
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of a novel cell cycle-related risk signature predicting prognosis in patients with pancreatic adenocarcinoma.
    Xu D; Qin R; Li M; Shen J; Mao Y; Tang K; Zhang A; Wang D; Shi Y
    Medicine (Baltimore); 2022 Nov; 101(46):e29683. PubMed ID: 36401386
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Hyperthermia-induced stellate cell deactivation to enhance dual chemo and pH-responsive photothermal therapy for pancreatic cancers.
    Hu Q; Xu M; Feng J; Xie H; Li J; He Y; Tang G; Guo B
    Nanoscale; 2022 Nov; 14(42):15735-15748. PubMed ID: 36205175
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. TGF-β1/smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a.
    Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liu Z; Liao B
    J Mol Med (Berl); 2022 Oct; 100(10):1465-1478. PubMed ID: 36001113
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Golgi scaffold protein PAQR3 as a candidate suppressor of gastric cardia adenocarcinoma via regulating TGF-β/smad pathway.
    Wu YL; Hong LL; Ling ZN; Hu XY; Liu Z; Li P; Ling ZQ
    J Clin Lab Anal; 2022 Sep; 36(9):e24617. PubMed ID: 35870178
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/smad3 signaling.
    Zhang Z; Xu Y
    Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Proteomics Approach Highlights Early Changes in Human Fibroblasts-pancreatic Ductal Adenocarcinoma Cells Crosstalk.
    Damiani V; Cufaro MC; Fucito M; Dufrusine B; Rossi C; Del Boccio P; Federici L; Turco MC; Sallese M; Pieragostino D; De Laurenzi V
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406724
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.